Sabra Health Care REIT remains a Buy, supported by improving fundamentals and an attractive valuatio

Sabra Health Care REIT is rated 'Buy' with a $24.50/share price target, reflecting undervaluation an

Senior Housing REITs are outperforming major indices, driven by a persistent supply-demand imbalance

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #SBRA--In conjunction with upcoming investor meetings, Sab

Barclays analyst Richard Hightower maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Equal-We

Baird analyst Vikram Malhotra maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and r

Amundi increased its stake in shares of Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 22.7% in the u

Wall Street analysts change outlook on top names. See all rating changes, upgrades, downgrades and i

Wall Street analysts made some dramatic moves on Thursday, slashing price targets by double digits o

Raymond James analyst David Rodgers upgrades Sabra Health Care REIT (NASDAQ:SBRA) from Underperfo

Sabra Health Care REIT, Inc. (SBRA) Q2 2026 Earnings Call Transcript

Sabra Healthcare REIT NASDAQ: SBRA reported second-quarter 2026 normalized funds from operations of

Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.4 per share, beati

Sabra Health Care REIT (NASDAQ:SBRA) lowers FY2026 FFO guidance from $1.55-$1.59 to $1.53-$1.55 vs $

Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.39 per share which met the an

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #2Q26--Sabra Health Care REIT, Inc. (“Sabra,” the “Company

Investors looking for stocks in the REIT and Equity Trust - Other sector might want to consider eith

First Trust Advisors LP lifted its position in Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 99.4% d

Entropy Technologies LP increased its position in shares of Sabra Healthcare REIT, Inc. (NASDAQ: SBR

Sabra Health Care REIT, Inc. (“Sabra” or the “Company”) (Nasdaq: SBRA) today released its si

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #ESG--Sabra Health Care REIT, Inc. (“Sabra” or the “Compan

Baird analyst Wesley Golladay maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and r

Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Buy

Citizens analyst Aaron Hecht maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Market Outperf

Sabra (SBRA) was a big mover last session on higher-than-average trading volume. The latest trend in

The company should soon find new tenants for 26 of its properties. These incoming tenants will pay a

Sabra Health Care REIT, Inc. ("Sabra," the "Company" or "we") (NASDAQ:SBRA)

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #GUIDANCE--Sabra Health Care REIT, Inc. (“Sabra,” the “Com

TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #2Q26--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announc

Welltower grew revenue and normalized funds from operations by double-digit percentages. Sabra has a

UBS analyst Michael Goldsmith maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and l

Truist Securities analyst Michael Lewis upgrades Sabra Health Care REIT (NASDAQ:SBRA) from Hold t

Barclays analyst Richard Hightower initiates coverage on Sabra Health Care REIT (NASDAQ:SBRA) wit

Citigroup analyst Nick Joseph downgrades Sabra Health Care REIT (NASDAQ:SBRA) from Buy to Neutral

Scotiabank analyst Nicholas Yulico maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Sector P

Raymond James analyst David Rodgers reinstates Sabra Health Care REIT (NASDAQ:SBRA) from Market P

Coca-Cola is Kevin Simpson's final trade; AbbVie gets upgraded and Sabra Health Care and UnitedH

Wells Fargo analyst John Kilichowski maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overwe

Scotiabank analyst Nicholas Yulico maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Sector P

UBS analyst Michael Goldsmith maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and r

Cantor Fitzgerald analyst Richard Anderson maintains Sabra Health Care REIT (NASDAQ:SBRA) with a

Sabra Health Care REIT (NASDAQ:SBRA) affirms FY2026 FFO guidance from $1.55-$1.59 to $1.55-$1.59 vs

Sabra Health Care REIT (NASDAQ:SBRA) reported quarterly earnings of $0.39 per share which beat the a

Wells Fargo analyst John Kilichowski maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Overwe

Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Hol

Scotiabank analyst Nicholas Yulico maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Sector P

UBS analyst Michael Goldsmith maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Neutral and r

Citigroup analyst Nick Joseph maintains Sabra Health Care REIT (NASDAQ:SBRA) with a Buy and raise